Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VC0P
|
|||
Drug Name |
Piperazinyl norbenzomorphane compound 3
|
|||
Synonyms |
PMID30185082-Compound-34
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H29N3O2
|
|||
Canonical SMILES |
CN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
|
|||
InChI |
1S/C24H29N3O2/c1-25-11-13-26(14-12-25)20-7-8-21-19-9-10-27(23(15-19)22(21)16-20)24(28)29-17-18-5-3-2-4-6-18/h2-8,16,19,23H,9-15,17H2,1H3
|
|||
InChIKey |
CQQWIHMDQBNBBE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1644629-60-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.